Oxygenta Pharmaceutical Ltd - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015 And In Terms Of Aforesaid SEBI Circular Dated May 20, 2020 And All Other Applicable Regulations.

Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve With respect to the above cited subject, this is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Tuesday, the 30th of May, 2023 to consider and approve the following: 1. To consider and approve the Audited Financial Results of the Company for the period ended 31st March, 2023. 2. Other Corporate matters. In furtherance to our previous intimation with respect to Closure of trading window, this is to inform you that the Trading window of the Company for all the designated persons and their immediate relatives will remain closed till 48 hours from the conclusion of the Board meeting. This is for your information and records.